Rik Hermanides

726 total citations · 1 hit paper
14 papers, 301 citations indexed

About

Rik Hermanides is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Rik Hermanides has authored 14 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Rik Hermanides's work include Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (9 papers) and Cardiac Imaging and Diagnostics (6 papers). Rik Hermanides is often cited by papers focused on Coronary Interventions and Diagnostics (11 papers), Acute Myocardial Infarction Research (9 papers) and Cardiac Imaging and Diagnostics (6 papers). Rik Hermanides collaborates with scholars based in Netherlands, Belgium and Italy. Rik Hermanides's co-authors include Jurriën M. ten Berg, Sjoerd H. Hofma, Ton A.C.M. Heestermans, Johannes C. Kelder, Laura M. Willemsen, Clemens von Birgelen, Melvyn Tjon Joe Gin, Marieke E. Gimbel, Michiel Voskuil and Thomas O. Bergmeijer and has published in prestigious journals such as The Lancet, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Rik Hermanides

10 papers receiving 299 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

2020 212 citations Marieke E. Gimbel, Laura M. Willemsen et al. The Lancet profile →

Peers

Countries citing papers authored by Rik Hermanides

Since Specialization

Citations

This map shows the geographic impact of Rik Hermanides's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rik Hermanides with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rik Hermanides more than expected).

Fields of papers citing papers by Rik Hermanides

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rik Hermanides. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rik Hermanides. The network helps show where Rik Hermanides may publish in the future.

Co-authorship network of co-authors of Rik Hermanides

This figure shows the co-authorship network connecting the top 25 collaborators of Rik Hermanides. A scholar is included among the top collaborators of Rik Hermanides based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rik Hermanides. Rik Hermanides is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Preoperative intra-aortic balloon pump in patients with ST-elevation myocardial infarction undergoing urgent cardiac bypass surgery 2024 ·Netherlands Heart Journal ·(unknown), (unknown), (unknown), (unknown), Rik Hermanides, Jan-Henk Dambrink, M. Gosselink, Vincent Roolvink, Maarten van Leeuwen, Jan Paul Ottervanger	0
2	Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach 2022 ·American Journal of Cardiovascular Drugs ·Enrico Fabris, (unknown), (unknown), Rik Hermanides, Elvin Kedhi, Gianfranco Sinagra, Arnoud W.J. van ‘t Hof	4
3	Treatment and prognosis of elderly patients with non-ST-elevation myocardial infarction 2022 ·European Heart Journal ·Walter W. van den Broek, (unknown), Rik Hermanides, (unknown), Robert F. Storey, David Austin, Rohit M. Oemrawsingh, (unknown), Gavin Galasko, (unknown), (unknown), Salem H.K. The, Martin G. Stoel, Arnoud W.J. van ‘t Hof, J M Ten Berg	0
4	Feasibility and safety of cangrelor in patients with suboptimal P2Y12 inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry 2021 ·BMC Cardiovascular Disorders ·(unknown), (unknown), Willem L. Bor, (unknown), Saman Rasoul, E. Kaplan, Koen Teeuwen, Sjoerd H. Hofma, Erik Lipšic, Giovanni Amoroso, (unknown), Jurriën M. ten Berg, Arnoud W.J. van ‘t Hof, Rik Hermanides	2
5	Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial breakdown → 2020 ·The Lancet ·Marieke E. Gimbel, (unknown), Laura M. Willemsen, Rik Hermanides, Thomas O. Bergmeijer, (unknown), Ton A.C.M. Heestermans, Melvyn Tjon Joe Gin, Reinier A. Waalewijn, Sjoerd H. Hofma, Frank den Hartog, J. Wouter Jukema, Clemens von Birgelen, Michiel Voskuil, Johannes C. Kelder, Vera H.M. Deneer, Jurriën M. ten Berg	212
6	Lack of statin therapy is associated with plaque instability in non-culprit non-ischemic lesions of diabetic patients – data from the COMBINE OCT-FFR study 2020 ·European Heart Journal ·Balázs Berta, Tomasz Roleder, Rik Hermanides, Alexander Ijsselmuiden, Fernándo Alfonso, Floris Kauer, Javier Escaned, Giuseppe De Luca, William F. Kennedy, Wojciech Wojakowski, Elvin Kedhi	0
7	The 1‑year safety and efficacy outcomes of Absorb bioresorbable vascular scaffolds for coronary artery disease treatment in diabetes mellitus patients: the ABSORB DM Benelux study 2019 ·Netherlands Heart Journal ·(unknown), Rik Hermanides, Saman Rasoul, Balázs Berta, Alexander Ijsselmuiden, (unknown), Edouard Benit, Bruno Pereira, Giuseppe De Luca, Elvin Kedhi	5
8	Everolimus-eluting bioresorbable scaffolds for treatment of coronary artery disease in patients with diabetes mellitus: the midterm follow-up of the prospective ABSORB DM Benelux study 2019 ·Cardiovascular Diabetology ·(unknown), Rik Hermanides, Saman Rasoul, Balázs Berta, Alexander Ijsselmuiden, Gillian A.J. Jessurun, Edouard Benit, Bruno Pereira, Giuseppe De Luca, Elvin Kedhi	8
9	Resolute zotarolimus‐eluting stent in ST‐elevation myocardial infarction (resolute‐STEMI): A prespecified prospective register from the DAPT‐STEMI trial 2019 ·Catheterization and Cardiovascular Interventions ·(unknown), Enrico Fabris, Martin van der Ent, Rik Hermanides, Paweł Buszman, Clemens von Birgelen, Stéphane Cook, Hans Wedel, Giuseppe De Luca, Ronak Delewi, Felix Zijlstra, Elvin Kedhi	0
10	Use, timing and outcome of coronary angiography in patients with high-risk non-ST-segment elevation acute coronary syndrome in daily clinical practice: insights from a ‘real world’ prospective registry 2018 ·Netherlands Heart Journal ·Erik Badings, Rik Hermanides, Aize van der Sluis, J. H. E. Dambrink, A.T. Marcel Gosselink, Elvin Kedhi, Jan Paul Ottervanger, Vincent Roolvink, Wouter Remkes, (unknown), Harry Suryapranata, Arnoud W.J. van ‘t Hof	8
11	Fractional Flow Reserve–Guided Deferred Versus Complete Revascularization in Patients With Diabetes Mellitus 2016 ·The American Journal of Cardiology ·Mark Kennedy, Rik Hermanides, E. Kaplan, (unknown), Enrico Fabris, Petra C. Koopmans, Jan‐Henk E. Dambrink, A.T. Marcel Gosselink, Arnoud W.J. van ‘t Hof, Jan Paul Ottervanger, Vincent Roolvink, Wouter Remkes, Aize van der Sluis, Harry Suryapranata, Elvin Kedhi	17
12	Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus 2016 ·Cardiovascular Diabetology ·Mark Kennedy, E. Kaplan, Rik Hermanides, Enrico Fabris, (unknown), Petra C. Koopmans, (unknown), A.T. Marcel Gosselink, Arnoud W.J. van ‘t Hof, Jan Paul Ottervanger, Vincent Roolvink, Wouter Remkes, Aize van der Sluis, Harry Suryapranata, Elvin Kedhi	30
13	Early or late intervention in patients with transient ST‐segment elevation acute coronary syndrome: Subgroup analysis of the ELISA‐3 trial 2016 ·Catheterization and Cardiovascular Interventions ·Erik Badings, Wouter Remkes, Salem H.K. The, Jan‐Henk E. Dambrink, Geert Tjeerdsma, Saman Rasoul, Jorik R. Timmer, (unknown), Dirk J. Lok, Rik Hermanides, Jan van Wijngaarden, Harry Suryapranata, Arnoud W.J. van ‘t Hof	12
14	Treatment of ST-elevation Myocardial Infarction 2008 ·Future Cardiology ·Rik Hermanides, Jan Paul Ottervanger	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact